surveillance: create transparency, abuse of leave
, for emphasis:
Health - 02 October 2009 - Press release
surveillance studies are investigations that are important additional information from the practice of already approved drugs can be won. If you are a statutory instrument under the Monitoring of drugs after their approval. Properly used, they contribute to improving the application quality and drug safety. The possibility of abuse as a marketing tool is not acceptable.
The associations of doctors and health insurance in the statutory health insurance obtained through a legal obligation on pharmaceutical companies with extensive information about surveillance. The pharmaceutical companies apply to the contracts and the monitoring plan including cash to the Federal Medical Association. These documents contain the names of participating doctors, the level of compensation, and Further details of the observational study such as the time, the target and the tested drug. The Ministry points out that the legislature does not allow regulation premiums in observational studies. may only be paid reasonable compensation for the additional expense incurred. Here, the medical associations are asked to reveal professional misconduct and sanction.
explained to discussing the surveillance of the Secretary, Federal Ministry of Health, Dr. Klaus Theo Schroeder: "The legislature has in recent years for a transparent Meldeverfahren gesorgt und die Gesetzeslage verschärft. Damit wurden insbesondere der ärztlichen Selbstverwaltung Möglichkeiten gegeben, mit den ihr zugehenden Daten die Qualität von Anwendungsbeobachtungen zeitnah zu bewerten und entsprechend zu handeln. Jetzt ist die Selbstverwaltung gefordert! Sie muss Missbrauch abstellen, Transparenz herstellen und die gesetzlich gegebenen Möglichkeiten anwenden.””
0 comments:
Post a Comment